Selected article for: "canine melanoma and small study"

Title: Research Communications of the 27(th) ECVIM-CA Congress: Intercontinental, Saint Julian's, Malta, 14th to 16th September 2017
  • Document date: 2017_11_7
  • ID: roslkxeq_320
    Snippet: Mucosal melanoma is an aggressive disease that carries a poor prognosis, no effective systemic treatments are currently available to control the progression of metastatic disease. This small study showing some efficacy in end stage disease, indicates that masitinib offers potential for treatment of canine melanoma. Further studies in earlier stage disease and possibly in combination with other modalities are needed to support our findings......
    Document: Mucosal melanoma is an aggressive disease that carries a poor prognosis, no effective systemic treatments are currently available to control the progression of metastatic disease. This small study showing some efficacy in end stage disease, indicates that masitinib offers potential for treatment of canine melanoma. Further studies in earlier stage disease and possibly in combination with other modalities are needed to support our findings.

    Search related documents:
    Co phrase search for related documents
    • aggressive disease and early stage disease: 1, 2, 3
    • aggressive disease and end stage disease: 1, 2
    • aggressive disease and metastatic disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11
    • aggressive disease and metastatic disease progression: 1
    • aggressive disease and poor prognosis: 1, 2, 3, 4, 5, 6
    • aggressive disease and small study: 1, 2
    • aggressive disease and stage disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • aggressive disease and systemic treatment: 1, 2, 3, 4, 5
    • canine melanoma and Mucosal melanoma: 1
    • canine melanoma and small study: 1
    • early stage disease and end stage disease: 1, 2, 3
    • early stage disease and metastatic disease: 1, 2, 3, 4, 5, 6
    • early stage disease and poor prognosis: 1, 2, 3, 4
    • early stage disease and small study: 1, 2
    • early stage disease and stage disease: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43, 44, 45, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55, 56, 57, 58, 59, 60, 61, 62, 63, 64, 65, 66, 67, 68, 69, 70, 71, 72, 73, 74, 75, 76
    • early stage disease and systemic treatment: 1
    • effective systemic treatment and poor prognosis: 1
    • effective systemic treatment and systemic treatment: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18
    • efficacy show and metastatic disease: 1, 2